MEFV and familial Mediterranean fever: Allelic variant 2 was significantly more frequent in the subgroup of FMF patients MEFV(-) than in healthy controls (p = 0.001) and the carriers also had a higher risk of development of amyloidosis or arthritis (p = 0.026) than other FMF patients into the same group [11].